News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arteriocyte, Inc. Awarded Ohio Third Frontier Funding for Company's STEM-PREP and NANEX Technologies


4/30/2009 1:33:24 PM

CLEVELAND--(BUSINESS WIRE)--Arteriocyte announced today a $4.99 Million award from the Ohio Third Frontier Commission’s Research Commercialization Program. The award will be used to expand clinical applications for Arteriocyte’s commercially available Magellan Platelet Rich Plasma (PRP) and bone marrow derived stem cell product “STEM-PREP” and will further the company’s development of its NANEX stem cell expansion technology for Blood Pharming.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES